Revision of the EU pharmaceutical legislation

Written By Guest User

The European Commission has published a revision of pharmaceutical legislation, marking the most significant reform of the bloc's pharma rules in 20 years. This comprehensive overhaul is set to make a substantial impact in Europe and globally. PAREA has actively contributed input leading up to its publication and remains engaged in shaping the legislation during the institutional negotiations phase.

Guest User
Previous

PAREA Founder speaking at the PSYCH Symposium
Next

A need for a coordinated EU action on psychedelic therapies